← til store investorer
NEA Management Company, LLC
kapitalforvalter · portefølje $1.59 mia. · 26 positioner · rapport pr. 30.06.2026
Aktiepositioner rapport for 30.06.2026, indsendt 14.08.2026; ændring — mod 31.03.2026 · 27
| Selskab | Aktier | Værdi | % af porteføljen | Ændring i kvartalet |
|---|---|---|---|---|
| Trevi Therapeutics Inc US:TRVI | 13 222 228 | $247 mio. | 15.53% | — |
| MBX Biosciences, Inc. US:MBX | 3 614 486 | $200 mio. | 12.56% | — |
| Monte Rosa Therapeutics Inc US:GLUE | 7 692 298 | $186 mio. | 11.72% | — |
| Celcuity LLC US:CELC | 1 710 561 | $179 mio. | 11.27% | −575 000 |
| SpyGlass Pharma, Inc. US:SGP | 7 392 301 | $165 mio. | 10.36% | — |
| Savara Inc US:SVRA | 24 471 264 | $151 mio. | 9.49% | — |
| Zenas BioPharma, Inc. US:ZBIO | 4 023 219 | $102 mio. | 6.43% | — |
| Coursera, Inc. US:COUR | 12 867 769 | $72.6 mio. | 4.57% | — |
| Aurinia Pharmaceuticals Inc US:AUPH | 3 969 834 | $67.4 mio. | 4.24% | — |
| CRISPR Therapeutics AG CUSIP H17182108 | 1 058 570 | $57.7 mio. | 3.64% | — |
| Oric Pharmaceuticals, Inc. US:ORIC | 4 118 621 | $44.6 mio. | 2.81% | — |
| Phathom Pharmaceuticals Inc US:PHAT | 1 960 169 | $21.3 mio. | 1.34% | — |
| Korro Bio, Inc. US:KRRO | 1 297 893 | $17.1 mio. | 1.08% | — |
| X4 Pharmaceuticals, Inc. CUSIP 98420X103 | 3 233 743 | $15.1 mio. | 0.95% | — |
| Champions Oncology Inc US:CSBR | 1 713 720 | $10.6 mio. | 0.66% | — |
| Nkarta Inc US:NKTX | 3 568 781 | $10.1 mio. | 0.64% | — |
| CVRx Inc US:CVRX | 1 954 440 | $10.0 mio. | 0.63% | −71 643 |
| Black Diamond Therapeutics I… US:BDTX | 4 448 757 | $8.23 mio. | 0.52% | — |
| Karyopharm Therapeutics Inc. US:KPTI | 576 780 | $5.64 mio. | 0.35% | ny |
| INVENTIVA US:IVA | 1 462 586 | $5.53 mio. | 0.35% | — |
| LeonaBio, Inc. US:LONA | 464 398 | $4.27 mio. | 0.27% | — |
| Senti Biosciences, Inc. CUSIP 81726A209 | 3 775 615 | $4.15 mio. | 0.26% | — |
| Marker Therapeutics Inc US:MRKR | 1 625 678 | $2.39 mio. | 0.15% | — |
| OnKure Therapeutics, Inc. US:OKUR | 478 548 | $2.18 mio. | 0.14% | — |
| ImageneBio, Inc. US:IMA | 50 005 | $295 t. | 0.02% | — |
| Gossamer Bio, Inc. CUSIP 38341P102 | 1 000 000 | $165 t. | 0.01% | — |
| Arcellx, Inc. CUSIP 03940C100 | 0 (var 3 045 262) | — | — | solgt |
I virksomheder i vores database 14
| Selskab | Andel | Aktier | Rapportdato |
|---|---|---|---|
| SpyGlass Pharma, Inc. | 22.11% | 7 392 301 | 2026-06-30 |
| Minerva Surgical Inc | 19.39% | 1 721 853 | 2023-09-30 |
| Marker Therapeutics Inc | 9.75% | 1 625 678 | 2026-06-30 |
| Trevi Therapeutics Inc | 9.28% | 13 222 228 | 2026-06-30 |
| Monte Rosa Therapeutics Inc | 9.02% | 7 692 298 | 2026-06-30 |
| Korro Bio, Inc. | 8.81% | 1 297 893 | 2026-06-30 |
| Black Diamond Therapeutics I… | 7.74% | 4 448 757 | 2026-06-30 |
| MBX Biosciences, Inc. | 7.51% | 3 614 486 | 2026-06-30 |
| CVRx Inc | 7.34% | 1 954 440 | 2026-06-30 |
| Zenas BioPharma, Inc. | 5.93% | 4 023 219 | 2026-06-30 |
| Nkarta Inc | 4.98% | 3 568 781 | 2026-06-30 |
| LeonaBio, Inc. | 4.94% | 464 398 | 2026-06-30 |
| Celcuity LLC | 3.5% | 1 710 561 | 2026-06-30 |
| Aurinia Pharmaceuticals Inc | 2.98% | 3 969 834 | 2026-06-30 |
annonce
